Results 221 to 230 of about 2,176,861 (324)
Birch pollen and PM10 are key determinants of clinical symptoms, particularly in asthma. Allergic people react stronger to the pollen collected in the highly polluted area than in the less polluted areas. When evaluating the effectiveness of allergen immunotherapy, it is essential to consider not only pollen concentrations but also levels of air ...
Maria Czarnobilska +5 more
wiley +1 more source
K. Latha, Dr. Nikee Minz, Ms. Akanksha Bharti, Ms. Chinkey Kumari4, Ms. Khushboo Kumari, Mr. Ratan Singh, Ms. Shweta Singh, Mr. Shivam Kumar +7 more
openalex +1 more source
Chronic cough and chronic pruritus in older adults: a population-based cross-sectional study. [PDF]
Bollemeijer JF +5 more
europepmc +1 more source
Spatial Transcriptomics Identifies Characteristic Immunological Niches in Atopic Dermatitis
Spatially organized immune niches containing mature migratory dendritic cells (mmDCs) and CD4+ T cells in atopic dermatitis lesions support localized T cell activation and may contribute to disease persistence. Spatial transcriptomics identifies conserved immune niches in atopic dermatitis lesions, characterized by close co‐localization of CD4+ T cells
Lina Gross +11 more
wiley +1 more source
Chronic Pruritus Severity and Its Association with Clinical Frailty in Geriatric Dermatology Patients: A Cross-Sectional Study. [PDF]
Kurmuş GI +3 more
europepmc +1 more source
Compartment‐resolved transcriptomic profiling of AD, PsO, and clinically ambiguous AD‐PsO overlap lesions reveals molecular heterogeneity, with overlap lesions showing relative alignment toward AD‐like or PsO‐like patterns. AD‐like alignment is associated with epidermal barrier and dermal neural/sensory pathways, whereas PsO‐like alignment is ...
Jongeun Lee +9 more
wiley +1 more source
From chronic pruritus to painful swelling: A rare vulvar transformation. [PDF]
Yadav K, Chayashree S, Puri P.
europepmc +1 more source
In this Phase 2a trial, severely peanut‐allergic participants were randomized to abatacept versus placebo with peanut oral immunotherapy (OIT) for 24 weeks, followed by 12 weeks of OIT alone. No significant difference was observed for the primary efficacy outcome (the relative change from baseline in peanut‐specific/total IgE ratio at 24 weeks), but ...
Marie‐Lee Simard +12 more
wiley +1 more source

